A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy
Clinical trial NCT01649297 · COMPLETED
Trial details
- NCT number
- NCT01649297
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-12-01
- Enrollment
- 983
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.